Advertising, generic competition and price egulation in pharmaceutical markets

CESifo Economic Studies

Volumn 52, Issue 3, 2006, Pages 565-586

  Königbauer, Ingrid ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETITION (ECONOMICS); DRUGS TRADE; PHARMACEUTICAL INDUSTRY; PRICE DYNAMICS;

EID: 33750444233     PISSN: 1610241X     EISSN: None     Source Type: Journal    
DOI: 10.1093/cesifo/ifl009     Document Type: Article

References (17)

1. Brekke, K.R. and M. Kuhn (2006), "Direct-to-Consumer advertising in pharmaceutical markets", Journal of Health Economics 25, 102-130.
2. Cabrales, A. (2003), Pharmaceutical generics, vertical product differentiation, and public policy, Working Paper UPF 662.
3. Caves, R.E. Whinston, M.D. and M.A. Hurwitz (1992), "Patent expiration, entry, and competition in the U.S. pharmaceutical industry", Brookings Papers on Economic Activity: 1-48.
4. Danzon, P.M. and Chao, L.-W. (2000), "Does regulation drive out competition in pharmaceutical markets?", Journal of Law and Economics 43, 311-357.
5. Dixit, A. and V. Norman (1978), "Advertising and welfare", Bell Journal of Economics 9, 1-17.
6. Frank, R.G and D.S. Salkever (1992), "Pricing, patent loss and the market for pharmaceuticals", Southern Economic Journal 59, 165-179.
7. Frank, R.G. and D.S. Salkever (1997), "Generic entry and the market for pharmaceuticals", Journal of Economics & Management Strategy 6, 75-90.
8. Gabszewicz, J.J. and J. Thisse (1979), "Price competition, quality and income disparities", Journal of Economic Theory 20, 340-359.
9. Hellerstein, J. (1998), "The importance of the physician in the generic versus trade-name prescription decision", RAND Journal of Economics 29, 108-136.
10. Hurwitz, M.A. and R.E. Caves (1988), "Persuasion or information? promotion and the shares of brand name and generic pharmaceuticals", Journal of Law and Economics 31, 299-320.
11. Jacobzone, S. (2000), Pharmaceutical policies in OECD countries: Reconciling social and industrial goals, Labour Market and Social Policy-Occasional Papers No. 40, Organisation for Economic Cooperation and Development, Paris.
12. Königbauer, I. (2005), "Advertising and generic market entry", HEB Working Paper 3/2005, University of Bergen.
13. Lundin, D. (2000), "Moral hazard in physician prescription behavior", Journal of Health Economics 19, 639-662.
14. Sachverständigenrat zur Begutachtung der Entwicklung im Gesundheitswesen (2005), Gutachten 2005: Koordination und Qualität im Gesundheitswesen, Download: www.svr-gesundheit.de (16. Januar 2006).
15. Scherer, F.M. (2000), "The pharmaceutical industry", In: A.J. Culyer and J.P. Newhouse eds, Handbook of Health Economics, Volume I, Elsevier, Amsterdam.
16. Shaked, A. and J. Sutton (1982), "Relaxing price competition through product differentiation", Review of Economic Studies 99, 3-13.
17. Taggart, J. (1993), "The world pharmaceutical industry", Thomson Learning, London: Routledge.